Download PDF
SUPRAVENTRICULAR TACHYCARDIA (SVT)
[Back]

Fact Sheet Photo

What Is It?

Supraventricular tachycardia (SVT) is an unusually fast heart rhythm that happens when the heart rhythm (or pulse) is faster than 100 beats per minute. It is the most common rhythm disturbance in children and is rarely life threatening. SVT occurs when the heart’s electrical system has an irregularity. It can come on suddenly and improve on its own. It can occur for minutes to hours, but usually lasts 10-15 minutes.

Causes of SVT in athletes include:

• Intense exercise

• Anxiety

• Fever

• Infection

• Dehydration

• Hyperthyroidism (high thyroid hormone levels)

• Anemia

• Stimulant use

• Lung disease

• Heart disease

 

Symptoms/Risks

Symptoms of SVT may include:

• Palpitations (fast and hard heart beats)

• Heart feels like it skips a beat

• Lightheadedness

• Dizziness

• Feeling tired

Some patients may experience these additional symptoms:

• Trouble breathing

• Chest pain or chest tightness

SVT is more common in older patients with heart disease and is less common in younger athletic populations (unless there is a known heart condition).

 

Sports Medicine Evaluation & Treatment

Athletes during the pre-participation physical will get a full evaluation from a sports medicine physician. If the athlete has a history of symptoms related to the heart, including known heart disease, further evaluation will be ordered.

A sports medicine physician will review the symptoms and perform a physical exam with a complete cardiac test, including listening for heart abnormalities, checking for normal pulses, evaluating signs of abnormal swelling and any changes in the heart rhythm. The athlete will get an electrocardiogram to look at the heart rhythm to identity SVT. Screening electrocardiograms will rarely pick up SVT if the athlete has no symptoms. The physician may obtain blood work to check the thyroid, liver and kidneys during the initial evaluation. If there are abnormalities found during the initial work-up, the next step would likely include referral to a cardiologist to perform further specialized studies (i.e. stress test, echocardiogram) to evaluate for any cardiac disease. Additional studies may include wearing a heart monitor to record the heart’s electrical activity over several days and during physical activity.

Treatment regimens for SVT include:

• Medications to control the heat rhythm and rate.

• Treatment with cardioversion (applying electrical current to the heart).

• Treatment with ablation to destroy the area of the heart that is causing the abnormal electrical signals.

If the SVT was triggered by specific physical activity, anxiety, stress or other factors not directly due to heart abnormalities, modifications to these factors will be advised to reduce the risk of a repeat episode.

 

Injury Prevention

To prevent the onset of SVT it is important to:

• Stay hydrated during activity.

• Reduce anxiety and stressors.

• Maintain healthy nutrition.

• Train for endurance, strength, and conditioning.

• Educate athlete on symptoms to report to the physician.

• Report any family history of heart disease to the physician.

 

Return to Play

Once SVT evaluation is complete, return to play is dependent on the cause and treatment plan provided. In general, athletes with no further symptoms and no structural heart abnormalities will be cleared to play if their SVT is resolved or is properly controlled. If SVT is treated by medicine or a procedure, athletes may be able to return to play as long as they are symptom-free and there are no structural abnormalities or have no electrical heart risks. Return to play protocol will be sports specific.

AMSSM Member Authors
Tu Dan Kathy Nguyen, MD and Mark Chassay MD

References
1. Drezner JA, Ackerman MJ, Cannon BC, et al Abnormal electrocardiographic findings in athletes: recognising changes suggestive of primary electrical disease Br J Sports Med 2013;47:153-167.
2. Eligibility and Disqualification Recommendations for Competitive Athletes with Cardiovascular Abnormalities: A Scientific Statement from the American Heart Association and American College of Cardiology. J Am Coll Cardiol 2015;Nov 2.
3. Link MS. Evaluation and Initial Treatment of Supraventricular Tachycardia. New England Journal of Medicine. 2012;367(15):1438-1448. doi:10.1056/nejmcp1111259.
4. Page RL, Joglar JA, Caldwell MA, et al. 2015 ACC/AHA/HRS Guideline for the Management of Adult Patients With Supraventricular Tachycardia: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. J Am Coll Cardiol 2016; 67:e27.

Category: Cardiovascular (Heart) Issues, Chest and Abdomen,

[Back]

SPORTS MEDICINE TODAY NEWSLETTER

PODCASTS

HOME
WHAT IS A SPORTS MED PHYSICIAN?
ARTICLES
BEGINNER TRIATHLETE
POSITION STATEMENTS
AMSSM

FIND A SPORTS DOC

Please enter a search term relevant to the search type. For US States - use only letter abbreviations.
 
Choose Search Type
Enter Search Term

Zip Code:
Choose Search Radius:
2024 © The American Medical Society for Sports Medicine website created by  the computer geek
website security by: Website Guardian